Fulgent Genetics, Inc. FLGT Increase in accrued expenses and other liabilities
Increase in accrued expenses and other liabilities at other companies
Other financials
Where this comes from
Reported directly by Fulgent Genetics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities.
The official record: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →
Ask your AI about Fulgent Genetics, Inc.'s increase in accrued expenses and other liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Fulgent Genetics, Inc.'s increase in accrued expenses and other liabilities?
- Fulgent Genetics, Inc. (FLGT) reported increase in accrued expenses and other liabilities of -$2.12M in Q1 2026.
- How has Fulgent Genetics, Inc.'s increase in accrued expenses and other liabilities changed year-over-year?
- Fulgent Genetics, Inc.'s increase in accrued expenses and other liabilities increased by 71.6% year-over-year, from -$7.49M to -$2.12M.